SPAG11B (61-103) (Human) [7404]



SPAG11B (61-103) (Human)


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@H]1CSSC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CCCN2C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)NC1=O)[C@@H](C)CC
InChIKey NZRXPCZWIFPFBB-SZWZVGMQSA-N
Sequence DLLPPRTPPYQVHISHREARGPSFRICVDFLGPRWARGCSTGN
HELM PEPTIDE1{D.L.L.P.P.R.T.P.P.Y.Q.V.H.I.S.H.R.E.A.R.G.P.S.F.R.I.C.V.D.F.L.G.P.R.W.A.R.G.C.S.T.G.N}$PEPTIDE1,PEPTIDE1,27:R3-39:R3$$$

Chemical Properties

Hydrogen bond acceptors 65
Hydrogen bond donors 64
Rotatable bonds 121
Log P -21.596
Molecular weight (Da) 4856.4
Stereochemistry info partial

Database connections



No bioactivity data available.

SPAG11B (61-103) (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.